Rational Design of 5‘-Thiourea-Substituted α-Thymidine Analogues as Thymidine Monophosphate Kinase Inhibitors Capable of Inhibiting Mycobacterial Growth
Citations Over TimeTop 10% of 2007 papers
Abstract
Recently, thymidine monophosphate kinase (TMPK) emerged as an attractive target for developing inhibitors of Mycobacterium tuberculosis growth. The elucidation of the X-ray structure of TMPK of M. tuberculosis (TMPKmt), as well as the structure of an earlier serendipitously discovered dimeric thymidine inhibitor, laid the foundation for the design of potent and selective TMPKmt inhibitors reported here. Several hits identified within a series of 3'-C-branched thiourea-substituted beta-thymidine derivatives inspired us to construct a set of 5'-thiourea-substituted alpha-thymidine derivatives characterized by a similar relative orientation of the thymine and arylthiourea moieties. alpha-Thymidine derivative 15, featuring a (3-trifluoromethyl-4-chlorophenyl)thiourea moiety, has a Ki of 0.6 microM and a selectivity index of 600 versus human TMPK. Moreover, it represents the first TMPK inhibitor showing good inhibitory activity on growing M. bovis (MIC99 = 20 microg/mL) and M. tuberculosis (MIC50 = 6.25 microg/mL) strains.
Related Papers
- → Thymidine uptake, thymidine incorporation, and thymidine kinase activity in marine bacterium isolates(1990)36 cited
- → Synthesis of N3-Substituted Thymidine Analogues for Measurement of Cellular Kinase Activity(2008)6 cited
- → Salvage pathway of pyrimidine synthesis: Divergence of substrate specificity in two related species of teleostean fish(1996)10 cited
- → Phosphorylation of tritiated thymidine by L929 mouse fibroblasts(1969)68 cited
- → Characteristics of spontaneous and induced thymidine and 5-iodo-2-deoxyuridine resistant clones of mouse lymphoma cells(1974)32 cited